Skip to main content
Caplight Logo









Nutrivert

Nutrivert

Private
Atlanta, GeorgiaHealthcare & Life Scienceshttps://nutrivert.com

Last Round

Series A

Extension

Apr 10, 2026

Total Funding Raised

$1.69M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Nutrivert operates in Healthcare & Life Sciences and is based in Atlanta, Georgia. Its latest recorded funding round was a Series A round in March 2023.

Nutrivert is an agtech company developing non-antibiotic feed additives designed to improve animal health and feed efficiency in livestock production.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Nutrivert Comparables

Compare Nutrivert with similar companies based on industry and business-model similarity.

Nutrivert comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Proteon Pharmaceuticals
78%
Cargill
73%
dsm-firmenich
68%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Nutrivert Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionApr 10, 2026
Series AMar 1, 2023
GrantOct 1, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Nutrivert Investors

Notable investors and investment history

Nutrivert investors
InvestorRounds
Arrow VenturesSeries A Extension
Auburn University LAUNCH Innovation Grants ProgramGrant
Georgia Research AllianceGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 10, 2026

    $2.4M round led by Arrow Ventures

  • Mar 1, 2023

    $2M round raised

Book a demo to see all signals

For institutional investors. Book with your work email.

Nutrivert Filings

Explore SEC and related filing metadata, where available.

Nutrivert filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Nutrivert's valuation, stock price, and market status.

Is Nutrivert a public or private company?

Nutrivert is a private company.

What is the current stock price of Nutrivert?

Nutrivert is a private company, so its shares have no public market price. Caplight tracks Nutrivert's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Nutrivert worth (valuation)?

Valuation information for Nutrivert is not publicly available.

Can I buy Nutrivert stock?

Nutrivert shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Nutrivert's last funding round?

Nutrivert's most recent funding round was Series A Extension on April 10, 2026.

Who are the main investors in Nutrivert?

Key investors in Nutrivert include Arrow Ventures.

Will Nutrivert IPO soon?

No public IPO plans have been announced for Nutrivert.

How can I track Nutrivert secondary market activity?

Caplight tracks bids, offers, and trades in Nutrivert's shares on secondary markets.

Firmographic Details

HeadquartersAtlanta, Georgia
Employee Range1
Year Founded2016
Last FundingApr 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?